AQR Capital Management - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,573,792
-35.5%
476,800
-25.8%
0.01%
-33.3%
Q2 2023$8,641,839
+97.3%
642,994
+143.4%
0.02%
+80.0%
Q1 2023$4,380,834
+3.1%
264,224
+15.7%
0.01%0.0%
Q4 2022$4,248,798
-17.3%
228,430
-43.0%
0.01%
-23.1%
Q3 2022$5,140,000
+50.4%
400,631
-17.8%
0.01%
+62.5%
Q2 2022$3,418,000
-0.3%
487,541
+17.9%
0.01%
+14.3%
Q1 2022$3,428,000
+15.6%
413,552
-5.6%
0.01%
+40.0%
Q4 2021$2,966,000
+17.7%
438,073
-7.8%
0.01%0.0%
Q3 2021$2,519,000
+35.1%
475,317
+46.6%
0.01%
+66.7%
Q2 2021$1,864,000
-44.1%
324,198
-55.2%
0.00%
-40.0%
Q1 2021$3,336,000
+0.5%
723,653
-27.2%
0.01%
-16.7%
Q4 2020$3,318,000
+31.5%
993,431
+16.9%
0.01%
+50.0%
Q3 2020$2,523,000
-39.7%
849,532
-6.2%
0.00%
-42.9%
Q2 2020$4,182,000
-10.4%
905,244
-25.3%
0.01%
-12.5%
Q1 2020$4,668,000
+9.7%
1,212,449
+6.8%
0.01%
+60.0%
Q4 2019$4,257,000
+381.6%
1,135,144
+581.5%
0.01%
+400.0%
Q3 2019$884,000
-17.9%
166,570
-40.6%
0.00%0.0%
Q2 2019$1,077,000
+237.6%
280,438
+348.0%
0.00%
Q1 2019$319,000
+19.0%
62,597
-55.2%
0.00%
Q4 2018$268,000
-64.3%
139,842
-29.6%
0.00%
-100.0%
Q3 2018$751,000
-35.9%
198,596
-47.1%
0.00%0.0%
Q2 2018$1,171,000
-38.9%
375,396
-53.2%
0.00%
-50.0%
Q1 2018$1,918,000
+45.7%
802,697
+138.5%
0.00%
+100.0%
Q4 2017$1,316,000
+48.0%
336,578
-4.6%
0.00%0.0%
Q3 2017$889,000
+469.9%
352,626
+453.2%
0.00%
Q4 2015$156,000
-62.8%
63,742
-54.3%
0.00%
-100.0%
Q3 2015$419,000
-45.1%
139,562
-24.5%
0.00%
-50.0%
Q2 2015$763,000
-4.6%
184,7820.0%0.00%0.0%
Q1 2015$800,000
+27.8%
184,782
-12.4%
0.00%
+100.0%
Q4 2014$626,000
-21.6%
210,882
-12.2%
0.00%
-50.0%
Q3 2014$798,000
+31.2%
240,2820.0%0.00%0.0%
Q2 2014$608,000
+33.6%
240,282
+19.4%
0.00%
+100.0%
Q1 2014$455,000
+55.8%
201,282
+34.5%
0.00%0.0%
Q4 2013$292,000149,6820.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 159,791$1,8685.34%
Opaleye Management Inc. 1,205,000$14,086,4504.58%
GABLES CAPITAL MANAGEMENT INC. 431,955$5,049,5543.51%
JW Asset Management, LLC 563,392$6,586,0522.85%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,192,000$95,764,4802.11%
Seaport Global Advisors, LLC 45,941$537,0501.61%
Capital Impact Advisors, LLC 67,067$784,0131.31%
Ikarian Capital, LLC 505,862$5,913,5270.71%
MOODY ALDRICH PARTNERS LLC 273,512$3,197,3550.61%
Paradiem, LLC 166,905$1,951,1190.59%
View complete list of CATALYST PHARMACEUTICALS INC shareholders